Health

  • November 05, 2026

    Albertsons, Safeway Owe Wash. $900M Over Opioid Diversion

    Albertsons and its Safeway subsidiary must pay $900 million for helping fuel Washington state's overdose crisis by failing for years to prevent the diversion of opioid drugs, a Seattle judge ruled Thursday, finding that the pharmacy chains regularly failed to follow their own policies aimed at ensuring prescriptions were legitimate.

  • November 04, 2026

    Pharmacy Worker Says Dosage Machine Cut Off Fingertip

    A pharmacy worker suffered a "traumatic" finger amputation when a machine that dispenses liquid medication caught her index finger and ripped part of it off, according to a lawsuit in Pennsylvania state court that accuses medical device manufacturer Precision Products Group Inc. of defective design.

  • November 04, 2026

    Anthem Fights Rework Of Neurosurgery Group Antitrust Case

    A pair of Anthem units are pushing back against a Long Island, New York, neurosurgery practice's bid to file an amended complaint accusing the insurer of driving down reimbursement rates, telling a New York federal court the changes fail to fix the problems that resulted in a previous dismissal.

  • November 04, 2026

    Colo. Co. Accused Of Misusing $400K Loan For HHS Deal

    A Colorado public benefit corporation breached a loan agreement by failing to use the $400,000 loan for its intended purpose and instead diverting the loan to settle a nearly $600,000 civil penalty with a federal government agency, according to a lender's lawsuit in Colorado state court.

  • November 04, 2026

    Anti-Pot Group Eyes New Repeal Pushes After Mass. Loss

    After Election Day, anti-cannabis activists are pledging to bring repeal efforts to other states despite a decisive defeat in Massachusetts, while pro-cannabis industry and consumer-focused groups say they hope to work with a Democrat-controlled Congress to secure federal reform.

  • November 04, 2026

    2nd Circ. Told To Not Expand Antitrust Patent Fraud Standing

    A pharmaceutical industry trade group has backed Bristol-Myers Squibb and its Celgene subsidiary in the Second Circuit, warning that health plans asking the appeals court to reinstate a proposed class action against the companies are seeking to expand who can bring antitrust cases alleging fraudulently obtained patents.

  • November 04, 2026

    AGs Say Taro's $200M MDL Deal Doesn't Bar Their Claims

    Dozens of state attorneys general urged a Connecticut federal judge Tuesday not to let Taro Pharmaceuticals block a swath of their price-fixing claims with a $200 million settlement it struck with plaintiffs in separate multidistrict litigation, arguing the claims and plaintiffs are too separate to bind one another.

  • November 04, 2026

    Walgreens Seeks Sanctions In Investors' Pharma Growth Suit

    Walgreens has asked an Illinois federal judge to sanction investors and their attorneys in a securities fraud class action, arguing they continued to falsely attribute statements about the company's plans to open hundreds of clinics to a former executive even after a recording showed his statement was taken out of context.

  • November 04, 2026

    4 Argument Sessions For Benefits Attys To Watch In Nov.

    JPMorgan Chase & Co. will defend its win in a 401(k) forfeiture suit at the Ninth Circuit, Aetna will ask the Second Circuit to push a multiemployer health plan's suit into arbitration, and the Tenth Circuit hears from pharmacy benefit managers who want an opioid nuisance battle moved to federal court. Here, Law360 looks at four arguments that benefits attorneys may want to keep an eye on in November.

  • November 04, 2026

    Mass. Justices Doubt Nantucket's Rationale For PFML Denial

    Massachusetts' highest court appeared to push back Wednesday on assertions by Nantucket that it cannot implement the state's Paid Family and Medical Leave Act for employees of the island enclave, despite a town meeting vote, because some of its unions have not agreed to bargain over the cost.

  • November 04, 2026

    Highmark Health Network Hit With Suit Over AI Recording Use

    Allegheny Health Network and its parent Highmark Health failed to get informed consent from patients for use of an artificial intelligence-based clinical documentation tool in exam rooms, according to a patient's proposed class action complaint in Pennsylvania state court.

  • November 04, 2026

    MVP: Holland & Knight's Jennifer Weaver

    Dubbed the "Queen of the False Claims Act" by an opposing counsel, Jennifer Weaver of Holland & Knight LLP convinced the government to drop its investigation into California's Cedars-Sinai Medical Center and successfully defended a Puerto Rican cardiologist against FCA and kickback claims, earning her a spot as one of the 2026 Law360 Healthcare MVPs.

  • November 04, 2026

    EU Committees OK Tighter Controls On Drug Inputs

    Two European Parliament committees voted Wednesday to advance draft measures they said would strengthen controls on chemicals used to manufacture illegal drugs like heroin and cocaine.

  • November 04, 2026

    Abortion Measures Split State Voters In Midterm Election

    Reproductive and gender-affirming care rights were on ballots in several states Tuesday night, as the Idaho electorate rejected a measure that would have overturned its anti-abortion laws, while voters in Nevada and other states passed measures expanding abortion protections.

  • November 04, 2026

    CVS To Split In 2, Unraveling Decade-Old Megamerger

    CVS Health said Wednesday that it plans to split into two independent, publicly traded companies, separating its Aetna- and Caremark-led healthcare businesses from its 9,000 retail pharmacy locations, reversing its nearly decade-old combination of the businesses.

  • November 03, 2026

    Va., Mo. Voters Deliver Wins For Abortion Rights

    Supporters of abortion access won key victories Tuesday in Virginia and Missouri as voters across the country took up healthcare measures that will shape state laws on reproductive and gender-affirming care, according to partial, unofficial returns.

  • November 03, 2026

    Mass., Idaho Voters Defeat Anti-Cannabis Ballot Measures

    Voters in Massachusetts and Idaho on Tuesday rejected efforts to repeal or restrict marijuana legalization, dealing a blow to anti-cannabis activists and lawmakers who sought to turn Election Day into a referendum on voter-led efforts to reform drug laws.

  • November 03, 2026

    New Calif. Governor Promises Litigation-Heavy Agenda

    Former state attorney general and U.S. Health and Human Services Secretary Xavier Becerra's projected win in the California governor's race Tuesday night tees up fresh legal battles with the Trump administration and puts immigration, insurance and artificial intelligence policy at the top of lawyers' watch lists.

  • November 03, 2026

    Feds Dropping Charges Against Harvard Researcher

    The government is dropping charges against a Harvard researcher and Russian national who was found with preserved clawed frog embryo samples at Boston's Logan International Airport last year, according to a filing Tuesday evening.

  • November 03, 2026

    Birth Control Clip Maker Must Face Injury Case Trial

    Medical device importer and distributor CooperSurgical Inc. failed to secure quick wins on several claims in a bellwether product liability case alleging injuries from Filshie Clip birth control devices, with a Connecticut state judge finding that federal law does not preempt six women's failure-to-warn allegations.

  • November 03, 2026

    Ga. Court Affirms Toss Of $7.5M Verdict In Patient Death Suit

    A Georgia appeals court on Tuesday affirmed a trial judge's decision to wipe out a jury's $7.5 million verdict against healthcare providers accused of negligently discharging an emergency room patient who was later hit and killed by a car, saying the plaintiffs failed to prove the providers' alleged negligence caused the death.

  • November 03, 2026

    Youth File Fresh Appeal In Colo. Hospital Gender Care Suit

    Transgender youth patients of Children's Hospital Colorado have brought yet another challenge to a judge's discharge of their contempt citation against the hospital for not resuming providing them medical gender-affirming care, this time asking the Colorado Court of Appeals to weigh in on whether the hospital complied with an injunction.

  • November 03, 2026

    3M Inks $7.35B Deal To Settle Most PFAS Foam Claims

    3M Co. announced Tuesday that it will pay up to $7.35 billion over nine years to resolve nearly all personal injury claims related to PFAS "forever chemicals" in firefighting foam.

  • November 03, 2026

    PBM Says Fla. Collusion Suit Belongs In Federal Court

    A pharmacy benefit manager accused by Florida's attorney general of colluding with a competitor to fix prescription drug reimbursement rates for pharmacies removed the state's suit to federal court, citing its work for federal and military employees.

  • November 03, 2026

    Mallinckrodt Loses $9.5M Award, Wins Delay In Airgas Drug

    A Delaware federal judge on Tuesday threw out Mallinckrodt Pharmaceuticals' $9.5 million jury award it won in an infringement case and instead blocked a competitor's inhaled nitric oxide treatment patent until after a pair of Mallinckrodt's patents expire.

Expert Analysis

  • 3 Strategies To Reduce AI Sycophancy In Legal Work

    Author Photo

    The tendency of generative artificial intelligence models to tell users what they want to hear can reinforce attorneys’ confirmation bias when testing the strength of arguments, and it can’t simply be prompted away — but a few practices can help mitigate it, says Michael Ott at Ice Miller.

  • DOJ Directive Gives Contractors A Fraud Risk Road Map

    Author Photo

    For government contractors, the 10 factors described in the U.S. Department of Justice's recent corporate fraud enforcement directive function as a de facto scoring rubric for internal audits that mirrors what prosecutors will prioritize, say attorneys at Spencer Fane.

  • 2nd Circ. EFAA Ruling Shifts Employer Litigation Strategy

    Author Photo

    In Diaz-Roa v. Hermes Law, the Second Circuit recently held that, under the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act, employers can't carve out nonharassment claims and send them to arbitration, which has implications for discovery, litigation costs and resolution strategy in EFAA-covered disputes, say attorneys at Krevolin Horst.

  • 3rd Circ. Ruling Opens Door For Fraud-On-The-Market Rethink

    Author Photo

    The Third Circuit's recent decision in Ocugen, holding that a stable stock price after publication of restated financials does not prove immateriality, could be a vehicle for the U.S. Supreme Court to overturn the doctrine undergirding certification of securities class actions, says Jonathan Richman at Brown Rudnick.

  • Series

    Being In The Peace Corps Made Me A Better Lawyer

    Author Photo

    When I served in the Peace Corps, the people of the West African village where I was stationed helped me acclimate to my new surroundings and enabled me to develop problem-solving, teamwork and empathy skills that have bolstered my legal practice far beyond the ability to offer technical advice, says Brian Bewley at McGuireWoods.

  • A Nuanced Reading Of DOL's Mental Health Parity Guidance

    Author Photo

    Though a recent U.S. Department of Labor bulletin may suggest that agency enforcement pressure on group health plans with respect to mental health parity is easing, the takeaways are more complex, and plan sponsors should not relax compliance efforts, say attorneys at Proskauer.

  • 6th Circ. Spotlights Cannabis Contract Enforceability Risks

    Author Photo

    The Sixth Circuit's recent reversal of a $31.8 million jury verdict against a subsidiary of cannabis giant Curaleaf highlights that state licenses do not necessarily provide the legal foundation needed to enforce contracts in federal court, which is a pattern that appears across many sectors, say attorneys at ArentFox Schiff.

  • Series

    A Day In The In-House Life: CHAI GC Talks Balance

    Author Photo

    On a typical day working in healthcare technology from home, Coalition for Health AI Head of Operations and General Counsel Brenton Hill shares his experience on everything from developing responsible artificial intelligence initiatives to discussing contracting strategies, all while navigating the blurred lines between home and work.

  • Where DOJ's Fraud Directive May Actually Affect Enforcement

    Author Photo

    The U.S. Department of Justice’s recent directive outlining corporate fraud enforcement priorities is mostly a management document instead of a policy, but one part may actually undermine the directive's goals by leading to worse outcomes for organizational defendants and less corporate self-disclosure, says Zachary Warren at Williams & Connolly.

  • FTC Hospital Review Shows Hurdles To Failing-Firm Defense

    Author Photo

    The Federal Trade Commission's recent announcement about Fairfield Medical Center's abandoned sale to OhioHealth shows why financially distressed sellers must conduct an adequate buyer search before using the failing-firm defense to argue that enforcers should overlook competition concerns, say attorneys at Alston & Bird.

  • Importer Risk Rises As AI Enters Trade Fraud Enforcement

    Author Photo

    The Trump administration's new data-driven and artificial intelligence-enabled push against tariff evasion raises the stakes for companies with global supply chains, making it crucial that they consider strengthening response protocols, documentation and internal reporting mechanisms, say attorneys at Cooley.

  • What CMS Audit Rule Means For Medicare Advantage Plans

    Author Photo

    Despite ongoing legal challenges, the Centers for Medicare & Medicaid Services is moving forward with implementation of its risk adjustment data validation audits, raising statistical concerns around overpayments indicated by variance in unbalanced samples, say Stephen Fink, Brad Rice and Igor Karagodsky at Analysis Group.

  • Parsing The Latest Signals On FTC Section 5 Enforcement

    Author Photo

    Federal Trade Commission cases brought over the last several years and Commissioner Mark Meador’s recent call for stand-alone Section 5 enforcement suggest businesses should prepare for continued scrutiny of conduct beyond traditional antitrust violations, particularly in essential goods, technology and labor markets, say attorneys at Axinn.

  • Why Vaccine Court Inoculates Drugmakers Against Litigation

    Author Photo

    Most claimants alleging injuries from routine childhood vaccines must complete an administrative compensation proceeding before they can sue in civil court — and recent legislative efforts aimed at weakening vaccine manufacturers' legal protections do not account for the important reasons the existing framework was put in place, say attorneys at Goldman Ismail.

  • What Lawyers Should Know Before Accepting Crypto Payment

    Author Photo

    As clients increasingly request to pay legal fees, retainers and escrow funds using cryptocurrency, lawyers should consider how only a handful of state bar authorities have addressed the issue with varying ethics opinions, as well as the related questions that no authority has yet answered, says attorney Felix Shipkevich.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.